Apimeds Pharmaceuticals US, Inc.
APUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001894525
No open-market purchases or sales by Apimeds Pharmaceuticals US, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $383.7K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Apimeds Pharmaceuticals US, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Apimeds Pharmaceuticals US, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Inscobee Inc. | 10% Owner | 2,099,747 | Nov 21, 2025 | 1 |
| O'Donnell Carol A | Director | – | Nov 13, 2025 | 2 |
| Kogan Elona Esq. | Director | – | Nov 13, 2025 | 2 |
| Weintraub Bennett | Director | – | Nov 13, 2025 | 2 |
| Yoon Hankil | Director | – | Nov 13, 2025 | 2 |
| Koo Jakap | Director | 643,885 | Nov 13, 2025 | 2 |
| Emerson Erik C. | Chief Executive Officer | 750,000 | Oct 17, 2025 | 1 |
| Kim Christopher | Chairman and CMO | 277,500 | Oct 17, 2025 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 (view filing) | May 13-14 | 2 days | Kim ChristopherChairman and CMO | PPurchaseCommon Stock, par value $0.01 per share | +27.5K | $1.83 | +$50.4K | New position27.5K after | 2 lots |
| May 14, 2025 (view filing)5:52 PM ET | May 12 | 2 days | Inscobee Inc.10% Owner | PPurchaseCommon Stock, par value $0.01 per share | +500.0K | $4.00 | +$2.00M | +33.7%1.98M after | From original |
| May 14, 2025 (view filing) | May 12 | 2 days | Koo JakapDirector | PPurchaseCommon Stock, par value $0.01 per share | +28.5K | $1.99 | +$56.7K | +4.6%643.9K after |